648 related articles for article (PubMed ID: 16050909)
1. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
4. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
5. Principles of treatment for mast cell tumors.
Govier SM
Clin Tech Small Anim Pract; 2003 May; 18(2):103-6. PubMed ID: 12831070
[TBL] [Abstract][Full Text] [Related]
6. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
Taylor F; Gear R; Hoather T; Dobson J
J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
[TBL] [Abstract][Full Text] [Related]
7. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia.
Litster AL; Sorenmo KU
J Feline Med Surg; 2006 Jun; 8(3):177-83. PubMed ID: 16476559
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
11. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010).
Baginski H; Davis G; Bastian RP
J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400
[TBL] [Abstract][Full Text] [Related]
13. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases.
Michels GM; Knapp DW; DeNicola DB; Glickman N; Bonney P
J Am Anim Hosp Assoc; 2002; 38(5):458-66. PubMed ID: 12220031
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
15. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
Fröberg GK; Lindberg R; Ritter M; Nordlind K
J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
[TBL] [Abstract][Full Text] [Related]
16. Canine subcutaneous mast cell tumor: characterization and prognostic indices.
Thompson JJ; Pearl DL; Yager JA; Best SJ; Coomber BL; Foster RA
Vet Pathol; 2011 Jan; 48(1):156-68. PubMed ID: 21078881
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases.
O'Connell K; Thomson M
Vet Comp Oncol; 2013 Mar; 11(1):51-62. PubMed ID: 22235766
[TBL] [Abstract][Full Text] [Related]
18. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival.
Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU
Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367
[TBL] [Abstract][Full Text] [Related]
19. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL
J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs.
Simpson AM; Ludwig LL; Newman SJ; Bergman PJ; Hottinger HA; Patnaik AK
J Am Vet Med Assoc; 2004 Jan; 224(2):236-40. PubMed ID: 14736068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
